| Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia DY Kim, YD Joo, SN Lim, SD Kim, JH Lee, JH Lee, DH Kim, K Kim, ... Blood, The Journal of the American Society of Hematology 126 (6), 746-756, 2015 | 176 | 2015 |
| Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer JG Kim, YS Chae, SK Sohn, YY Cho, JH Moon, JY Park, SW Jeon, IT Lee, ... Clinical Cancer Research 14 (1), 62-66, 2008 | 157 | 2008 |
| COVID-19 transmission and blood transfusion: A case report HJ Cho, JW Koo, SK Roh, YK Kim, JS Suh, JH Moon, SK Sohn, DW Baek Journal of Infection and Public Health 13 (11), 1678-1679, 2020 | 130 | 2020 |
| Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma MK Song, JS Chung, JJ Lee, SY Jeong, SM Lee, JS Hong, A Chong, ... Cancer science 104 (12), 1656-1661, 2013 | 112 | 2013 |
| Clonal hematopoiesis is associated with risk of severe Covid-19 KL Bolton, Y Koh, MB Foote, H Im, J Jee, CH Sun, A Safonov, R Ptashkin, ... Nature communications 12 (1), 5975, 2021 | 108 | 2021 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 104 | 2023 |
| Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse TH Kim, JH Moon, JS Ahn, YK Kim, SS Lee, SY Ahn, SH Jung, DH Yang, ... Blood, The Journal of the American Society of Hematology 132 (15), 1604-1613, 2018 | 102 | 2018 |
| Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients SJ Seong, M Lim, SK Sohn, JH Moon, SJ Oh, BS Kim, HM Ryoo, ... Annals of oncology 24 (3), 756-760, 2013 | 95 | 2013 |
| New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2 YS Chae, SK Sohn, JG Kim, YY Cho, JH Moon, HJ Shin, JS Chung, ... Bone marrow transplantation 40 (6), 541-547, 2007 | 94 | 2007 |
| Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer HC Lee, JG Kim, YS Chae, SK Sohn, BW Kang, JH Moon, SW Jeon, ... Journal of cancer research and clinical oncology 136, 1073-1078, 2010 | 84 | 2010 |
| Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer/T cell lymphoma HY Yhim, JS Kim, YC Mun, JH Moon, YS Chae, Y Park, JC Jo, SJ Kim, ... Biology of Blood and Marrow Transplantation 21 (9), 1597-1604, 2015 | 77 | 2015 |
| KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 … HJ Kim, HK Ahn, CW Jung, JH Moon, CH Park, KO Lee, SH Kim, YK Kim, ... Annals of hematology 92, 163-171, 2013 | 75 | 2013 |
| Prognostic value of metabolic tumor volume on PET/CT in primary gastrointestinal diffuse large B cell lymphoma MK Song, JS Chung, HJ Shin, JH Moon, JO Lee, HS Lee, SM Lee, ... Cancer science 103 (3), 477-482, 2012 | 73 | 2012 |
| Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients MK Kim, C Suh, DH Lee, CK Min, SJ Kim, K Kim, JH Moon, SS Yoon, ... Annals of oncology 22 (2), 411-416, 2011 | 72 | 2011 |
| Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer YS Chae, JG Kim, SK Sohn, YY Cho, BM Ahn, JH Moon, SW Jeon, ... Journal of Korean medical science 23 (3), 421, 2008 | 69 | 2008 |
| DNMT3A R882 mutation with FLT3-ITD positivity is an extremely poor prognostic factor in patients with normal-karyotype acute myeloid leukemia after allogeneic hematopoietic … JS Ahn, HJ Kim, YK Kim, SS Lee, SH Jung, DH Yang, JJ Lee, NY Kim, ... Biology of Blood and Marrow Transplantation 22 (1), 61-70, 2016 | 62 | 2016 |
| Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review BW Kang, SJ Lee, JH Moon, SN Kim, YS Chae, JG Kim, YJ Hwang, ... International journal of hematology 90 (3), 383-387, 2009 | 59 | 2009 |
| The clonal origins of leukemic progression of myelodysplasia T Kim, MS Tyndel, HJ Kim, JS Ahn, SH Choi, HJ Park, YK Kim, DH Yang, ... Leukemia 31 (9), 1928-1935, 2017 | 56 | 2017 |
| Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer YS Chae, JG Kim, SK Sohn, YY Cho, JH Moon, HI Bae, JY Park, MH Lee, ... Oncology 71 (3-4), 266-272, 2007 | 56 | 2007 |
| Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients JH Moon, SK Sohn, SN Kim, SY Park, SS Yoon, IH Kim, HJ Kim, YK Kim, ... Medical Oncology 29, 1179-1185, 2012 | 54 | 2012 |
